AAAAAA
Results:
1-18
|
Results: 18
Authors:
Kosmas, C
Tsavaris, N
Panopoulos, C
Vadiaka, M
Stavroyianni, N
Kourelis, T
Malamos, N
Antonopoulos, M
Kalofonos, HP
Citation: C. Kosmas et al., Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane plus platinum-based regimens, EUR J CANC, 37(8), 2001, pp. 972-978
Authors:
Kakolyris, S
Mavroudis, D
Tsavaris, N
Souglakos, J
Tsiafaki, P
Kalbakis, K
Agelaki, S
Androulakis, N
Georgoulias, V
Citation: S. Kakolyris et al., Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II study, ANN ONCOL, 12(2), 2001, pp. 193-197
Authors:
Stathopoulos, GP
Mavroudis, D
Tsavaris, N
Kouroussis, C
Aravantinos, G
Agelaki, S
Kakolyris, S
Rigatos, SK
Karabekios, S
Georgoulias, V
Citation: Gp. Stathopoulos et al., Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: A phase II study of the Greek Cooperative Group for Pancreatic Cancer, ANN ONCOL, 12(1), 2001, pp. 101-103
Authors:
Tsavaris, N
Kosmas, C
Vadiaka, M
Kontos, A
Katsorida, M
Dimitrakopoulos, A
Zerai, A
Koufos, C
Citation: N. Tsavaris et al., Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study, J EXP CL C, 20(1), 2001, pp. 29-34
Authors:
Polyzos, A
Tsavaris, N
Kosmas, C
Arnaouti, T
Kalahanis, N
Tsigris, C
Giannopoulos, A
Karatzas, G
Giannikos, L
Sfikakis, PP
Citation: A. Polyzos et al., Hypersensitivity reactions to carboplatin administration are common but not always severe: A 10-year experience, ONCOL-BASEL, 61(2), 2001, pp. 129-133
Authors:
Kosmas, C
Tsavaris, N
Vadiaka, M
Stavroyianni, N
Koutras, A
Malamos, N
Onyenadum, A
Rokana, S
Polyzos, A
Kalofonos, HP
Citation: C. Kosmas et al., Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens, CANCER, 92(11), 2001, pp. 2902-2910
Authors:
Polyzos, A
Kosmas, C
Tsavaris, N
Markopoulos, C
Kalahanis, N
Papadopoulos, O
Arnaouti, T
Sfikakis, PP
Citation: A. Polyzos et al., Doxorubicin plus ifosfamide as salvage treatment for patients with advanced breast cancer refractory to epirubicin plus cyclophosphamide, CLIN DRUG I, 19(5), 2000, pp. 349-355
Authors:
Tsavaris, N
Skarlos, D
Bacoyiannis, C
Aravantinos, G
Kosmas, C
Retalis, G
Panopoulos, C
Vadiaka, M
Dimitrakopoulos, A
Kostantinidis, K
Mitropoulos, D
Bougas, D
Pantazopoulos, D
Kosmidis, P
Citation: N. Tsavaris et al., Combined treatment with low-dose interferon plus vinblastine is associatedwith less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma, J INTERF CY, 20(8), 2000, pp. 685-690
Authors:
Mavroudis, D
Alexopoulos, A
Ziras, N
Malamos, N
Kouroussis, C
Kakolyris, S
Agelaki, S
Kalbakis, K
Tsavaris, N
Potamianou, A
Rigatos, G
Georgoulias, V
Citation: D. Mavroudis et al., Front-line treatment of advanced breast cancer with docetaxel and epirubicin: A multicenter phase II study, ANN ONCOL, 11(10), 2000, pp. 1249-1254
Authors:
Tsavaris, N
Kosmas, C
Mylonakis, N
Bacoyiannis, C
Kalergis, G
Vadiaka, M
Boulamatsis, D
Iakovidis, V
Kosmidis, P
Citation: N. Tsavaris et al., Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy, ANTICANC R, 20(6C), 2000, pp. 4777-4783
Authors:
Kosmas, C
Malamos, NA
Tsavaris, N
Antonopoulos, M
Citation: C. Kosmas et al., Chemotherapy-induced complete regression of choroidal metastases and subsequent isolated leptomeningeal carcinomatosis in advanced breast cancer: a case report and literature review, J NEURO-ONC, 47(2), 2000, pp. 161-165
Authors:
Tsavaris, N
Kosmas, C
Vadiaka, W
Kanelopoulos, P
Kontos, A
Katsorida, M
Agelopoulou, A
Vrizidis, N
Fotia, M
Papoutsis, K
Koufos, C
Citation: N. Tsavaris et al., Ondansentron and dexamethasone treatment with different dosing schedules (24 versus 32 mg) in patients with non-small-cell lung cancer under cisplatin-based chemotherapy: A randomized study, CHEMOTHERA, 46(5), 2000, pp. 364-370
Authors:
Polyzos, A
Tsavaris, N
Kosmas, C
Petrikos, G
Stamatiadis, D
Kalahanis, N
Giannopoulos, A
Karatzas, G
Sfikakis, PP
Citation: A. Polyzos et al., Double biochemical modulation of 5-fluorouracil by methotrexate and folinic acid for the treatment of advanced colorectal cancer, CLIN DRUG I, 17(2), 1999, pp. 83-88
Authors:
Polyzos, A
Tsavaris, N
Kosmas, C
Petrikos, G
Giannikos, L
Kalahanis, N
Papadopoulos, O
Christodoulou, K
Giannakopoulos, K
Veslemes, M
Katsilambros, N
Citation: A. Polyzos et al., Second-line chemotherapy with cisplatin-ifosfamide in patients with ovarian cancer previously treated with carboplatin-cyclophosphamide, J CHEMOTHER, 11(2), 1999, pp. 144-149
Authors:
Sipsas, NV
Aroni, K
Tsavaris, N
Mavragani, K
Paikos, S
Kordossis, T
Citation: Nv. Sipsas et al., AIDS-related cutaneous Kaposi's sarcoma: Failure of treatment with human chorionic gonadotropin, J CHEMOTHER, 11(1), 1999, pp. 78-79
Authors:
Androulakis, N
Kourousis, C
Dimopoulos, MA
Samelis, G
Kakolyris, S
Tsavaris, N
Genatas, K
Aravantinos, G
Papadimitriou, C
Karabekios, S
Stathopoulos, GP
Georgoulias, V
Citation: N. Androulakis et al., Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: A multicenter phase II study, J CL ONCOL, 17(6), 1999, pp. 1779-1785
Authors:
Polyzos, A
Tsavaris, N
Kosmas, C
Giannikos, L
Katsikas, M
Kalahanis, N
Karatzas, G
Christodoulou, K
Giannakopoulos, K
Stamatiadis, D
Katsilambros, N
Citation: A. Polyzos et al., A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer, ONCOL-BASEL, 56(4), 1999, pp. 291-296
Authors:
Koufos, C
Tsavaris, N
Travlou, A
Citation: C. Koufos et al., Unusual development of an abdominal neoplasm in a patient with Maffucci's syndrome, PANMIN MED, 40(4), 1998, pp. 338-342
Risultati:
1-18
|